Implantica AG (publ) announced that the RefluxStop procedure to treat acid reflux is now being successfully implemented at Spire Manchester Hospital, part of the Spire Healthcare Group.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.65 SEK | -0.87% | -3.86% | +19.87% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.87% | 744M | |
+71.84% | 12.28B | |
-19.62% | 8.08B | |
+16.02% | 7.23B | |
-6.42% | 5.29B | |
+4.54% | 4.93B | |
+18.62% | 4.19B | |
-21.30% | 4.13B | |
-40.16% | 2.24B | |
-3.47% | 2B |
- Stock Market
- Equities
- IMP A SDB Stock
- News Implantica AG
- Implantica AG Announces Spire Manchester Hospital in UK Begins Operating with RefluxStop™